Please login to the form below

Not currently logged in
Email:
Password:

vedolizumab

This page shows the latest vedolizumab news and features for those working in and with pharma, biotech and healthcare.

Takeda's ixazomib moves closer to US approval

Takeda's ixazomib moves closer to US approval

Takeda has high hopes for ixazomib, billing it as the company's second 'global launch' after ulcerative colitis therapy Entyvio (vedolizumab) - in other words a product that it will launch not

Latest news

More from news
Approximately 8 fully matching, plus 8 partially matching documents found.

Latest Intelligence

  • Interview: Trevor Smith, Takeda Interview: Trevor Smith, Takeda

    There's prostate cancer drug orteronel (TAK-700) and vedolizumab for Crohn's disease and ulcerative colitis, and then the atypical antipsychotic lurasidone. ... From among its product pipeline Smith picks prostate cancer drug orteronel (TAK-700),

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Adelphi Research UK

Adelphi Research UK is a healthcare insight partner. We uniquely blend robust market research with a consultancy approach, to guide...

Latest intelligence

An effective commercial model for cancer care
Patient-centric cancer care...
Blog_icon_understanding-the-adoption-ladder-in-closed-loop-marketing.png
Flexible content checklist – five questions to ask
To ensure that your content gets used by local markets and has a real impact, consider these questions when commissioning or developing core materials....
Experience design of physical spaces: a human-centred approach
Anna Tamasi from Blue Latitude Health highlights the key considerations and best practices for spatial design from a user experience design perspective....

Infographics